2019 / 05

Next Paper
DOI: 10.24075/brsmu.2019.060

ORIGINAL RESEARCH

Effects of carnosine and lipoic acid in the late stage of Parkinson’s disease in rats

Berezhnoy DS, Fedorova TN, Kulikova OI, Stavrovskaya AV, Abaimov DA, Gushchina AS, Olshansky AS, Voronkov DN, Stvolinsky SL
About authors

Research Center of Neurology, Moscow, Russia

Correspondence should be addressed: Olga I. Kulikova
Volokolamskoe shosse, 80, Moscow, 125367; ur.ygoloruen@avokiluk

About paper

Author contribution: Berezhnoy DS analyzed the literature; planned the study; acquired, analyzed and interpreted the obtained data; prepared the draft of the manuscript and revised its final version. Fedorova TN analyzed the literature; planned the study; analyzed and interpreted the obtained data; revised the manuscript. Kulikova OI analyzed the literature; planned the study; acquired, analyzed and interpreted the obtained data; revised the manuscript. Stavrovskaya AV analyzed the literature; planned the study; acquired, analyzed and interpreted the obtained data; prepared the draft of the manuscript. Abaimov DA acquired, analyzed and interpreted the obtained data; prepared the draft of the manuscript. Gushchina AS planned the study; acquired, analyzed and interpreted the obtained data; prepared the draft of the manuscript. Olshansky AS acquired and analyzed the data; prepared the draft of the manuscript. Voronkov DN acquired analyzed and interpreted the obtained data; prepared the draft of the manuscript. Stvolinsky SL planned the study; acquired, analyzed and interpreted the obtained data; prepared the draft of the manuscript.

Received: 2019-08-12 Accepted: 2019-08-30 Published online: 2019-09-18
|
  1. Sarkar S, Raymick J, Imam S. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives. Int J Mol Sci. 2016; 17 (6): E904. DOI: 10.3390/ijms17060904. PMID: 27338353.
  2. Illarioshkin SN, Slominsky PA, Shadrina MI, Bagyeva GKh, Zagorovskaya TB, Markova ED, et al. The heterogeneity of sporadic Parkinson's disease: a molecular approach to solving a problem. Annaly Klinicheskoy I Experimental`noy Nevrologii. 2007; 1 (1): 23–31. Russian.
  3. Mazzio EA, Reams RR, Soliman KF. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro. Brain Research. 2004; 1004 (1): 29–44.
  4. Jeon BS, Jackson-Lewis V, Burke RE. 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration. 1995: 4 (2): 131–7.
  5. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res. 2005; 39 (10): 1119–25. PMID: 7583676.
  6. Soto-Otero R, Mendez-Alvarez E, Hermida-Ameijeiras A, Muñoz-Patiño AM, Labandeira-Garcia JL. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem. 2000; 74 (4): 1605–12. DOI: 10.1046/j.1471-4159.2000.0741605.x. PMID: 10737618.
  7. Kulikova OI, Berezhnoy DS, Stvolinsky SL, Lopachev AV, Orlova VS, Fedorova TN. Neuroprotective effect of the carnosine — alpha-lipoic acid nanomicellar complex in a model of early-stage Parkinson's disease. Regul Toxicol Pharmacol. 2018; 95: 254–9. DOI: 10.1016/j.yrtph.2018.03.025. PMID: 2960191.
  8. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 6th Edition. San Diego: Academic Press, 2006. 456 p.
  9. Bolotova VTs, Krauz VA, Shustov EB. Biological model of experimental neurosis in laboratory animals. Biomedicina. 2015; (1): 66–80. Russian.
  10. Khudoerkov RM, Voronkov DN, Dikalova YuV. Quantitative morphochemical characteristics of the neurons of the rat brain's substantia nigra and its volume reconstruction. Bull experiment biol and medicine. 2013; 156 (6): 861–4. Russian.
  11. Kryzhanovsky GN, Magaeva SV, Trekova HA, Vetrila LA, Basharova LA, Atadzhanov MA. Participation of the serotonergic apparatus of the striatum in the Parkinsonian syndrome. Bull experiment biol and medicine. 1993; (5): 466–9. Russian.
  12. Zhao J, Shi L, Zhang LR. Neuroprotective effect of carnosine against salsolinol-induced Parkinson's disease. Exp Ther Med. 2017; 14 (1): 664–70.
  13. de Araujo DP, De Sousa CN, Araujo PV, Menezes CE, Sousa Rodrigues FT, Escudeiro S S, et al. Behavioral and neurochemical effects of alpha-lipoic Acid in the model of Parkinson's disease induced by unilateral stereotaxic injection of 6-OHDA in rat. Evid Based Complement Alternat Med. 2013; (1): 571–8.
  14. Di Stefano A, Sozio P, Cocco A, Iannitelli A, Santucci E, Costa M, et al. L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties. J Med Chem. 2006; 49 (4): 1486–93.
  15. Fedorova TN, Bagieva GH, Stepanova MS, Dobrotvorskaya MS, Ivanova-Smolenskaya IA, Polevaya EV, et al. Effectivity of carnosine in Parkinson's disease. Neurological bull. 2009; 41 (1): 24–9. Russian.